STOCK TITAN

Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 26, 2022 at 9:00am EDT

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Emergent BioSolutions Inc. (NYSE: EBS) announced its 2022 Annual Meeting of Stockholders will be held virtually on May 26, 2022, at 9:00 AM EDT. Stockholders of record can participate via live audio webcast, accessing the meeting through a designated website using their unique Control Number. Those without a Control Number can attend in listen-only mode. Full instructions for participation and ownership verification are available online. A replay of the meeting will also be accessible on the Emergent website.

Positive
  • None.
Negative
  • None.

GAITHERSBURG, Md., May 12, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that its 2022 Annual Meeting of Stockholders will be held in a virtual-only format via live audio webcast on Thursday, May 26, 2022 at 9:00 AM EDT.

HOW TO PARTICIPATE IN THE VIRTUAL ANNUAL MEETING
As described in the proxy materials, stockholders of record are eligible to participate in and ask questions during the Virtual Annual Meeting by visiting www.virtualshareholdermeeting.com/EBS2022 and entering their 16-digit Control Number provided on the proxy card, voting instruction form or notice received from the Company to log into this website. Only one stockholder per 16-digit Control Number can access the Virtual Annual Meeting.

Beneficial owners of shares held in street name will need to follow the instructions provided by the broker, bank or other nominee that holds their shares.

Those without a Control Number may attend as guests in listen-only mode and will not have the option to vote their shares or ask questions during the Virtual Annual Meeting.

ALL PARTICIPANTS ARE ENCOURAGED TO LOG IN AND ACCESS THE WEBCAST 15 MINUTES BEFORE THE VIRTUAL ANNUAL MEETING BEGINS.

Further instructions on how to attend, participate in and vote at the Virtual Annual Meeting, including how to demonstrate your ownership of the Company’s common stock as of the record date, are available at www.virtualshareholdermeeting.com/EBS2022.

A replay of the audio webcast will be made available on the Emergent website.

About Emergent BioSolutions
At Emergent, our mission is to protect and enhance life. For over 20 years, we’ve been at work defending people from things we hope will never happen—so we are prepared just in case they ever do. We provide solutions for complex and urgent public health threats through a portfolio of vaccines and therapeutics that we develop and manufacture for governments and consumers. We also offer a range of integrated contract development and manufacturing services for pharmaceutical and biotechnology customers. To learn more about how we plan to protect or enhance 1 billion lives by 2030, visit our website and follow us on LinkedIn, Twitter, and Instagram.

Investor Contact:
Robert G. Burrows
Vice President, Investor Relations
240-631-3280
burrowsr@ebsi.com  

Media Contact:
Matt Hartwig
Senior Director, Media Relations
mediarelations@ebsi.com


FAQ

What is the date and time of the Emergent BioSolutions Annual Meeting?

The Emergent BioSolutions Annual Meeting is scheduled for May 26, 2022, at 9:00 AM EDT.

How can stockholders participate in the Emergent BioSolutions Annual Meeting?

Stockholders can participate by logging into a virtual platform using their 16-digit Control Number provided in the proxy materials.

Can stockholders without a Control Number attend the meeting?

Yes, stockholders without a Control Number can attend in listen-only mode but cannot vote or ask questions.

Where can I find the instructions for attending the Annual Meeting?

Instructions for attending the Annual Meeting are available on the Emergent BioSolutions website.

Will there be a replay of the Annual Meeting?

Yes, a replay of the audio webcast will be available on the Emergent BioSolutions website after the meeting.

Emergent Biosolutions, Inc.

NYSE:EBS

EBS Rankings

EBS Latest News

EBS Stock Data

447.02M
53.08M
2.09%
60.01%
12.57%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
GAITHERSBURG